Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Lok Sabha nod to amended trademark law
New Delhi, Dec 18 (PTI) A person seeking global trade mark now need not apply for it in several countries incurring a big cost, as Lok Sabha today amended the trade mark law to simplify the procedures.

'Skyline' termed generic
The Supreme Court last week ruled that ‘Skyline’ is not a specific word on which a company can make a trade mark claim, as it has become a ‘generic’ name. In India 117 companies including software firms are using the word as part of their name. In the US there are 10 educational institutions with the same name as the first word. In the UK also there are two such institutions. Therefore, one company could not stake claim to the word in the name of trademark. The court made this ruling while dismissing the appeal case, Skyline Education Institute (India) Ltd vs S L Vaswani. It affirmed the judgement of the Delhi high court in this case, with minor modifications regarding admission of students to one institution. Both were educational institutions operating around the capital and they were litigating over the word ‘Skyline’.

News of the day

NTPC FPO to open on Feb 3
State-run power major National Thermal Power Corporation (NTPC) today said its follow-on public offer (FPO), through which the government plans to divest 5 per cent stake, would open on February 3.
Public Relations

Ranbaxy to launch generic version of Flomax next year

Pharma company Ranbaxy Laboratories today said it will launch a generic version of the urinary disorder treatment drug-- Flomax, next year. - Fortis in talks to buy Lanka hospital chain - Ranbaxy exits generic drugs JV with Japanese firm - Japan"s largest drug maker Takeda plans India foray - Sunny re-rating of pharma companies - "We are moving towards a larger addressable market" - Avon to gain from nod to Ranbaxy"s drug "We will launch a generic version of the urinary disorder treatment Flomax in March 2010," Ranbaxy Laboratories CFO Omesh Sethi told reporters on the sidelines of a seminar here. "We would launch another big one in 2014," he said, without naming it. "We are doing well and expect a good revenue from domestic and global markets in the next financial year," Sethi said.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009